Gilead Sciences, Inc. (Nasdaq: GILD) today announced the presentation of new Phase 3 ARTISTRY-1 and ARTISTRY-2 trial data at CROI 2026 showing a treatment switch to an investigational, single-tablet ...
Rather than bell-to-bell prohibitions, new app offers ‘airplane mode’ for schools that can be tweaked, teaching self-control, ...
Discord is launching teen-by-default settings globally in early March, adding privacy-forward age assurance, tighter access to age-gated spaces, and new default messaging and content filters.
Research indicates that a 4p pill could potentially aid those struggling with anxiety, low mood and lack of energy. If you ...
Research suggests a 4p vitamin supplement might help those with deficiency who are experiencing low mood, anxiety, and fatigue ...
Novo Nordisk will set a $675/month US list price (effective January 1, 2027) for Wegovy, Ozempic, and Rybelsus, targeting affordability for high-deductible and coinsurance designs. Impacted doses ...
A skin condition tied to delusions is posing a riddle for doctors: What to do when a diagnosis causes offense?
Vanda submitted data from iloperidone's schizophrenia and bipolar I disorder trials to the FDA to support the efficacy and ...
With component prices on the rise, it's never been more important to choose the right laptop for the long haul. Our latest ...
With these ten gadgets, life after 60 does not have to be complicated. Instead, it can be more organized, more connected, and ...
Dim indoor light and prolonged close focus may be quietly fueling the global rise in nearsightedness.
Over the past several years, to make kids “digitally literate,” we’ve plopped glowing laptops and tablets in front of many ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results